Skip to content

Join a 

Weight Loss Study

for Subcutaneous GLP-1* *Study medication is a GLP-1/GIP combination medication

Receive up to $5,300 For Your Time & Travel

Weight Loss Study - ACRC Trials
Weight Loss Study - ACRC Trials
ACRC-weightloss-1

Is This Study Right for You?

You may be eligible if you:

Discover Innovative Investigational Options for Managing Obesity

Joining an obesity clinical trial in Texas isn’t just about accessing potential new treatments. It’s a chance to better understand the complex nature of obesity while playing a role in important medical research.

ACRC-weightloss-2
ACRC-weightloss-3

Here’s How You Can Help Move Research Forward

Signing up is Easy by Following These 5 Simple Steps!

Please fill out the submission form provided below.

One of our friendly medical screeners will contact you.

The screener will organize a no-cost medical consultation and examination if you meet the eligibility criteria.

Your appointments will be scheduled, and you may receive study-related medication.

You may receive up to $5,300 for your time and travel.

Study Participants Receive:

ACRC-weightloss-4

What are GLP-1 and GIP?

GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) are naturally occurring hormones that help regulate blood sugar, appetite, and metabolism. They’re part of the body’s response to eating, helping control how insulin is released and how full you feel after meals. In obesity research, medications that mimic or enhance the effects of GLP-1 and GIP are showing promise for supporting weight loss and improving metabolic health. Combining both targets in one treatment may lead to even greater results than targeting either hormone alone.